- Home
- BCYC vs SOPH Comparison
BCYC vs SOPH Comparison
Compare BCYC & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BCYC | SOPH |
|---|---|---|
| Founded | 2009 | 2011 |
| Country | United Kingdom | Switzerland |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 360.7M | 367.7M |
| IPO Year | 2019 | 2021 |
Fundamental Metrics
Financial Performance| Metric | BCYC | SOPH |
|---|---|---|
| Price | $4.81 | $4.58 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 2 |
| Target Price | ★ $17.56 | $7.00 |
| AVG Volume (30 Days) | ★ 333.2K | 107.1K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 42.91 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $16.16 |
| Revenue Next Year | N/A | $17.56 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.00 | $2.58 |
| 52 Week High | $10.13 | $5.70 |
Technical Indicators
Market Signals| Indicator | BCYC | SOPH |
|---|---|---|
| Relative Strength Index (RSI) | 31.62 | 50.12 |
| Support Level | N/A | $4.54 |
| Resistance Level | $7.71 | $4.86 |
| Average True Range (ATR) | 0.27 | 0.29 |
| MACD | -0.02 | 0.03 |
| Stochastic Oscillator | 4.62 | 71.43 |
Price Performance
Historical ComparisonAbout BCYC Bicycle Therapeutics plc
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.